Compare IAC & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IAC | TWST |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.0B |
| IPO Year | 2020 | 2018 |
| Metric | IAC | TWST |
|---|---|---|
| Price | $38.83 | $44.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | $45.75 | ★ $48.75 |
| AVG Volume (30 Days) | ★ 965.7K | 903.2K |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.97 | 63.89 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,365,235,000.00 | $376,572,000.00 |
| Revenue This Year | N/A | $18.91 |
| Revenue Next Year | $0.48 | $15.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $29.56 | $23.30 |
| 52 Week High | $41.86 | $57.88 |
| Indicator | IAC | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 55.03 | 46.04 |
| Support Level | $38.29 | $41.65 |
| Resistance Level | $41.13 | $45.76 |
| Average True Range (ATR) | 1.05 | 2.66 |
| MACD | 0.14 | -0.06 |
| Stochastic Oscillator | 61.63 | 26.56 |
IAC Inc is comprised of businesses including Angi Inc, Dotdash Meredith and Care.com, among many others ranging from early stage to established businesses. Its Dotdash Meredith segment consists of its Digital and Print businesses. Angi segment offers repairing and remodeling homes to cleaning and landscaping services. Care.com segment is a online destination for families to connect with caregivers for their children, aging parents, pets and homes and for caregivers to connect with families seeking care services. Search segment consists of a collection of websites providing general search services and information, and a Desktop business, which includes business-to-business partnership operations.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.